That puts $USO in the $35-$40 range.
Time to start buying.
O.T. - $AMBS - "The next Amgen in its infancy".
On sale under eight cents.
Expecting 2015 will be a break-out year.
Read the recent Yahoo news.
Planned up-listing to the NASDAQ, spinning off diagnostic division, and launching first blood test to detect Alzheimer's plus numerous other products in its pipeline.
Twitter: @AmarantusBio .... 10,200 followers.
Which one offers 400% upside within three months? Hint: It's not MNKD.
Which one is likely to have a "big pharma" partner with in three months? Hint: It's not MNKD.
Which one has Dr. Joseph Rubinfeld one of the co-founders of Amgen on its advisory board? Hint: It's not MNKD.
Which one has Dr. Owen Garrick the former Co-Head of Mergers & Acquisitions at Novartis Pharmaceuticals on its advisory board? Hint: It's not MNKD.
Why concern yourself with warrants?
If you think the share price is going to .20 or .50 then buy shares at the open tomorrow. You may be able to get them under a dime.
Novartis for MANF in the diabetes field is also a possibility.
Uplisting to the NASDAQ in 2014.
So much potential for less than a dime. :)
p.s. Shorts are doomed. :(
One reasonable scenario for the recent buying is that the news of Marcum taking on Amarantus as a new client made it ways to the Marcum employees.
It's quite common that an accounting firm such as Marcum would update their offices and employees on a regular basis with a list of new clients with a profile of the company.
I can just imagine what a synopsis of Amarantus might have stated: "Micro cap bio-tech with both drug development and diagnostic divisions. Patented drug, MANF, has potential in the areas of Parkinson's, Alzheimer's, diabetes, T.B.I., Retinitis Pigmentosa, and numerous other potential orphan indications. Planned uplisting to the NASDAQ in 2014."
If I worked at Marcum and just heard about Amarantus for the first time I would buy a few shares. Wouldn't you?
I wonder what the thought process is that made the decision to short AMBS at four cents a rational decision.
Such mistakes can be costly as the shorts are finding out now.
AMBS - Most undervalued small cap bio-tech currently trading under a dime. $30M market cap.
Working with Becton Dickinson to develop LymPro, diagnostic test to detect early stage Alzheimers.
The company's patented drug, MANF, already has three orphan indications.
I have a dollar bill that was autographed by Neil Armstrong, Bob Hope, and Les Browne (Bob's band leader) in December 1969 when they were on the U.S.O. Christmas tour in Vietnam. I imagine it's a "one-of-a-kind".
Any idea what it might be worth?
Yellen isn't going to risk tanking the economy. Obama's approval rating is at an all time low.